Clinical trials
Phase 2 Genital Diseases, Female trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Xiaoxiang Chen | 2 |
| AGO Study Group | 1 |
| Belgian Gynaecological Oncology Group | 1 |
| Boston Children's Hospital | 1 |
| Catalysis SL | 1 |
| Catholic University of the Sacred Heart | 1 |
| Genexine, Inc. | 1 |
| HRA Pharma | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genital Diseases, Female | 16 |
| Neoplasms | 7 |
| Ovarian Diseases | 7 |
| Ovarian Neoplasms | 7 |
| Carcinoma | 6 |
| Genital Neoplasms, Female | 6 |
| Neoplasms by Site | 5 |
| Neoplasms, Glandular and Epithelial | 5 |
| Adnexal Diseases | 4 |
| Endocrine System Diseases | 4 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.